FDA 510k Approval
Micro Direct is pleased to announce the CO Check Pro breath carbon monoxide monitor has gained FDA 510k approval for in the USA.
Cigarette smoking is the leading cause of preventable disease and death in the US, accounting for more than 480,000 deaths per year (approximately 1 – 5 deaths) of which more than 140,000 of these deaths are from second hand smoke. (1)
As a country, we have a strong focus on smoking cessation encouraging current smokers to quit and highlighting the associated health benefits. Carbon Monoxide breath testing is a great and invaluable tool in assisting smokers to quit. The CO Check Pro with its clear display of a smokers exhaled carbon monoxide levels in parts per million (ppm) and percent carboxyhemoglobin (%COHb) levels along with visual colored lights on the levels of breath CO recorded, act as a great motivational tool in smoking cessation.
The CO Check Pro is easy to use and ensures the test can be performed quickly and efficiently assisting busy health care professionals in their role as smoking cessation advisers to reduce the burden of preventable deaths and disease associated with smoking.
1US Department of Health and Human Services. The Health Consequences of Smoking – 50 Years of Progress a Report of the Surgeon General.
